Skip to main content

Main menu

  • About
    • Our Mission
    • Donors
    • Board of Directors
    • Advisory Boards
    • Staff
    • Careers
    • FAQ
    • Annual Report
  • Why new TB Drugs?
    • Global Pandemic
    • Inadequate Treatment
    • Antimicrobial Resistance
    • Maternal and Child Health
    • Cycle of Poverty
    • Louder Than TB
  • R&D
    • Scientific Vision
    • Our Pipeline
    • Developing New Regimens
    • Discovery
    • Innovations
  • Access
    • Our Commitment
    • Understanding the TB Market
    • Engaging Communities
    • Introducing Products
  • Child Survival
    • Child-friendly medicines
    • Child TB Resources
  • News
    • Latest News
    • Publications
    • Voices of TB
    • Research Papers
  • Donate

Search form

Our Pipeline

  • Portfolio
  • Compounds
  • Regimens
  • Partners
  • Trials

Partners

TB Alliance works with a diverse network of global partners, including the world’s leading pharmaceutical developers, academic institutions, and research institutes. The following organizations are TB Alliance research and development partners.

  • Abbvie
  • Chugai
  • Daiichi Sankyo Novare
  • Eli Lilly
  • Foundation for Neglected Disease Research
  • GlaxoSmithKline
  • Harvard University
  • HyphaGenesis
  • IMPAACT
  • Institute of Materia Medica
  • Johns Hopkins University
  • Macleods
  • Medical Research Council at University College London
  • Merck
  • National Institutes of Health
  • OP-BIO
  • Roche Pharmaceuticals
  • Sanofi
  • Schrodinger
  • Stellenbosch University
  • Takeda Pharmaceuticals
  • TB Drug Accelerator Program
  • University College London
  • University of Auckland
  • University of Dundee
  • University of Illinois at Chicago
  • Yonsei University
Join our mailing list and receive the latest news from TB Alliance.
Interests

Our Mission

TB Alliance is a not-for-profit organization dedicated to the discovery and development of better, faster-acting, and affordable tuberculosis drugs that are available to those who need them.

Navigate

  • About
  • Why new TB Drugs?
  • R&D
  • Access
  • Child Survival
  • News
  • Donate

News Headlines

Statement on Civil Society Hearing on the UN High Level Meeting on Tuberculosis
TB Alliance Names Sandeep Juneja as Senior Vice President for Market Access
Global MPs Urge Heads of State to Act on Tuberculosis

Contact Us

Press Inquiries

C.J. Volpe
p | +1 646 616 8613
e | cj.volpe@tballiance.org

Thomas Lynch
p | +1 646 616 8639
e | thomas.lynch@tballiance.org

Jobs

View job openings at the TB Alliance

New York:

40 Wall Street, 24th floor, New York, NY 10005 • +1 212 227 7540

Pretoria:

Boardwalk Office Park, Block 1/Suite 5, 107 Haymeadow Street, Faerie Glen, Pretoria 0043, South Africa • +27 87 700 3900
© 2018 The TB Alliance. All Rights Reserved. Site by Darby Communications